Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy

被引:38
|
作者
Baslaim, MM
Al Malik, OA
Al-Sobhi, SS
Ibrahim, E
Ezzat, A
Ajarim, D
Tulbah, A
Chaudhary, MA
Sorbris, RA
机构
[1] King Faisal Specialist Hosp & Res Ctr, Dept Surg, Riyadh 11211, Saudi Arabia
[2] King Fahad Cent Hosp, Dept Surg, Jeddah, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Oncol, Riyadh 11211, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Riyadh 11211, Saudi Arabia
[5] King Faisal Specialist Hosp & Res Ctr, Dept Biostat Epidemiol & Sci Comp, Riyadh 11211, Saudi Arabia
来源
AMERICAN JOURNAL OF SURGERY | 2002年 / 184卷 / 04期
关键词
axillary lymph node retrieval; neoadjuvant chemotherapy; locally advanced breast cancer;
D O I
10.1016/S0002-9610(02)00959-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The purpose of this study was to assess our clinical impression that fewer lymph nodes are retrieved after level I and H axillary dissection after neoadjuvant chemotherapy and whether there is a positive correlation between the total number of lymph nodes retrieved and the number of diseased lymph nodes. Methods: Patients included those with stage IIB, IIIA, and IIIB breast cancer of whom 77 had neoadjuvant chemotherapy and 58 had initial surgery only. All had modified radical mastectomy with in continuity level I and II axillary dissection. Results: Patients after neoadjuvant chemotherapy had 14.3 +/- 6.7 lymph nodes detected versus 16.9 +/- 8.8 (mean +/- SD; P < 0.057) for those with initial surgery only. The number of positive nodes were 3.7 +/- 4.7 versus 6.6 +/- 8.7 (mean +/- SD; P < 0.033) respectively and the number of negative nodes were 10.6 +/- 7.5 versus 10.4 +/- 8 (mean +/- SD; P < 0.9). The correlation between the number of positive lymph nodes and the total number of lymph nodes was r = 0.58; P < 0.001. Conclusions: It appears that fewer lymph nodes are retrieved after level I and II axillary dissection after neoadjuvant chemotherapy. The total number of lymph nodes retrieved increases directly with the number of positive lymph nodes in patients not treated with chemotherapy. (C) 2002 Excerpta Medica, Inc. All rights reserved.
引用
收藏
页码:299 / 301
页数:3
相关论文
共 50 条
  • [21] Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation
    Hiroyuki Takei
    Takashi Yoshida
    Masafumi Kurosumi
    Kenichi Inoue
    Hiroshi Matsumoto
    Yuji Hayashi
    Toru Higuchi
    Sayaka Uchida
    Jun Ninomiya
    Kazuyuki Kubo
    Hanako Oba
    Shigenori Nagai
    Toshio Tabei
    [J]. International Journal of Clinical Oncology, 2013, 18 : 547 - 553
  • [22] Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy.
    Kang, SH
    Kim, SK
    Kwon, Y
    Ro, JS
    Kang, HS
    Lee, ES
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S173 - S173
  • [23] Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation
    Takei, Hiroyuki
    Yoshida, Takashi
    Kurosumi, Masafumi
    Inoue, Kenichi
    Matsumoto, Hiroshi
    Hayashi, Yuji
    Higuchi, Toru
    Uchida, Sayaka
    Ninomiya, Jun
    Kubo, Kazuyuki
    Oba, Hanako
    Nagai, Shigenori
    Tabei, Toshio
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (03) : 547 - 553
  • [24] Comparison of histopathologic evaluation of axillary sentinel lymph node compared to axillary contents after neoadjuvant chemotherapy
    Figueira, A. Filho
    Bezerra, S.
    Santos, A.
    Beltrao, J. Neto
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 37 - 37
  • [25] Axillary Lymph Node Dissection Should Not Be Avoided in Patients Who Undergo Neoadjuvant Chemotherapy for a Positive Sentinel Node after Targeted Axillary Staging
    Amersi, Farin
    Boyle, Marissa K.
    Rahimtoola, Rhea
    Chung, Alice
    Dang, Catherine
    Karlam, Scott
    Phillips, Edward
    Yuan, Yuan
    Jang, Julie
    Shiao, Stephen L.
    Giuliano, Armando E.
    Tseng, Joshua
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S91 - S91
  • [26] Nomogram for predicting axillary lymph node status after neoadjuvant chemotherapy in breast cancer
    Wang, Mengshen
    Wang, Mozhi
    Wang, Zhenning
    Song, Yongxi
    Gao, Peng
    Wang, Pengliang
    Wang, Chong
    Yu, Xueting
    Wei, Fengheng
    Guo, Jingyi
    Xu, Yingying
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (11) : 7054 - 7064
  • [27] ASO Author Reflections: Expectations in Axillary Lymph Node Dissections After Neoadjuvant Chemotherapy
    Fan, Betty
    James, Ted A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 112 - 113
  • [28] Axillary Lymph Node Response after Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
    Qureshi, I.
    Samiian, L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S50 - S50
  • [29] ASO Visual Abstract: Evaluating Axillary Lymph Node Yield After Neoadjuvant Chemotherapy
    Betty Fan
    Kelsey Romatoski
    Jaime Pardo
    Monica Valero
    Stephanie Serres
    Rene Flores
    Ted James
    [J]. Annals of Surgical Oncology, 2023, 30 : 114 - 114
  • [30] ASO Author Reflections: Expectations in Axillary Lymph Node Dissections After Neoadjuvant Chemotherapy
    Betty Fan
    Ted A. James
    [J]. Annals of Surgical Oncology, 2023, 30 : 112 - 113